|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| C07K 16/28 | |||
| C07K 16/46 |
| (11) | Patento numeris | 3192809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17153380.5 |
| Europos patento paraiškos padavimo data | 2013-04-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261636302 P | 2012-04-20 | US | |
| 201361768747 P | 2013-02-25 | US |
| (72) |
Barrett, Allan, US
Benschop, Robert Jan, US
Jirong, Lu, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES |
| ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES |